COMMUNIQUÉS West-GlobeNewswire

Whole Biome Announces Corporate Name Change to Pendulum Therapeutics
21/09/2019
SAN FRANCISCO, Sept. 20, 2019 (GLOBE NEWSWIRE) -- Whole Biome, an evidence-based microbiome company, announced today that it is changing its corporate name to Pendulum Therapeutics. The name change reflects the company’ [...]
Innate Pharma annonce le dépôt d’un document d’enregistrement Form-F1 en vue de son introduction en bourse envisagée aux Etats-Unis et le dépôt d’un Document d’Enregistrement Universel
20/09/2019
Marseille, France, le 20 septembre 2019, 23:30 INNATE PHARMA S.A. (Euronext Paris: IPH – ISIN: FR0010331421) (« Innate » ou la « Société »), une société de biotechnologie française spécialisée dans la découverte, le [...]
Innate Pharma files registration statement for proposed initial public offering in the United States
20/09/2019
Marseille, France, September 20, 2019 INNATE PHARMA S.A. (Euronext Paris: IPH – ISIN: FR0010331421) (“ Innate ” or the “ Company ”), a French biotechnology company focused on discovering, developing and commercializing [...]
KemPharm Provides Updates Regarding its Board of Directors
20/09/2019
CELEBRATION, Fla., Sept. 20, 2019 (GLOBE NEWSWIRE) -- KemPharm, Inc. (Nasdaq: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, announced today that, on [...]
Invitation to the special and extraordinary shareholders' meetings
20/09/2019
Mechelen, Belgium; 20 September 2019, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) invites its shareholders to a special and extraordinary shareholders' meeting. On 14 July 2019, [...]
IGM Biosciences Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
20/09/2019
MOUNTAIN VIEW, Calif., Sept. 20, 2019 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS) today announced the closing of its initial public offering of 12,578,125 shares of its common stock at a price to the public [...]
Invitation to the special and extraordinary shareholders' meetings
20/09/2019
Mechelen, Belgium; 20 September 2019, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) invites its shareholders to a special and extraordinary shareholders' meeting. On 14 July 2019, [...]
Emisphere Development Update
20/09/2019
ROSELAND, N.J., Sept. 20, 2019 (GLOBE NEWSWIRE) -- Novo Nordisk announced today the Federal Food and Drug Administration (FDA) has approved Rybelsus, a semaglutide tablet, for the treatment of adults with type 2 [...]
AVRA Medical Robotics Appoints Two World Renowned Professionals to Chair its Medical and Scientific Advisory Boards
20/09/2019
ORLANDO, Fla., Sept. 20, 2019 (GLOBE NEWSWIRE) -- AVRA Medical Robotics, Inc. (the “Company”) (OTCQB: AVMR), an emerging company which is building a fully autonomous medical robotic system through the use of new [...]
Healthcare Special Opportunities Fund Announces September 2019 Quarterly Distribution
20/09/2019
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 20, 2019 (GLOBE NEWSWIRE) -- ( TSX: MDS.UN ) – LDIC Inc. (the “ Manager ”), the manager of Healthcare Special [...]
Rybelsus® (semaglutide tablets), the first GLP-1 in a tablet approved in the US
20/09/2019
Bagsværd, Denmark, 20 September 2019 - Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Rybelsus ® (semaglutide tablets), as an adjunct to diet and exercise to improve glycaemic [...]
BriaCell Announces Private Placement of up to $600,000
20/09/2019
BERKELEY, Calif. and VANCOUVER, British Columbia, Sept. 20, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company [...]
Generex Announces That the Process to Retire 20,375,900 GNBT “Pool Shares” is Complete
20/09/2019
Retirement of Pool shares will be Reflected in 31.9% reduction in Outstanding Shares MIRAMAR, Fla., Sept. 20, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www. [...]
Aeterna Zentaris Announces Pricing of Approximately $5.0 Million Registered Direct Offering
20/09/2019
CHARLESTON, S.C., Sept. 20, 2019 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS), a specialty biopharmaceutical company engaged in commercializing novel pharmaceutical [...]
Coherus BioSciences Announces New Employment Inducement Grants
20/09/2019
REDWOOD CITY, Calif., Sept. 20, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that effective September 19, 2019, the compensation committee of the company’s board of directors [...]
Profound Medical Announces Closing of Offerings
20/09/2019
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES TORONTO, Sept. 20, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“ Profound ” or the “ Company ”) is pleased to [...]
Global Kinetics’ Personal KinetiGraph® (PKG®) Digital Wearable Technology Featured in Ten Posters at the International Congress of Parkinson’s Disease and Movement Disorders
20/09/2019
Results of new studies add to the growing body of data supporting the PKG as an important continuous, objective measure of movement for optimized management of Parkinson’s Disease PORTSMOUTH, N.H. and LONDON and [...]
Melinda Rombouts Named a 2019 RBC Canadian Women Entrepreneur Award Recipient in the Ones to Watch Category
20/09/2019
TORONTO, Sept. 20, 2019 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSXV: EVE; OTCQB: EEVVF) is pleased to announce that Melinda Rombouts, President and Chief Executive Officer of [...]
Nuvectra® Appoints Jennifer Kosharek as Chief Financial Officer
20/09/2019
PLANO, Texas, Sept. 20, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced the appointment of Jennifer Kosharek as Chief Financial Officer, effective [...]

Pages